These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21546086)

  • 1. No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma.
    Havranek O; Spacek M; Hubacek P; Mocikova H; Benesova K; Soucek P; Trneny M; Kleibl Z
    Leuk Res; 2011 Aug; 35(8):1117-9. PubMed ID: 21546086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma.
    Kim HN; Yu L; Kim NY; Lee IK; Kim YK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
    Am J Hematol; 2010 Oct; 85(10):822-4. PubMed ID: 20734458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
    Hosny G; Farahat N; Hainaut P
    Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha-308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt.
    Ibrahim A; Abdel Rahman H; Khorshied M; Sami R; Nasr N; Khorshid O
    Leuk Res; 2012 Jun; 36(6):694-8. PubMed ID: 22177457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
    Jiang P; Liu J; Zeng X; Li W; Tang J
    Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma.
    Chatzitolios A; Venizelos I; Tripsiannis G; Anastassopoulos G; Papadopoulos N
    Ann Hematol; 2010 Sep; 89(9):889-96. PubMed ID: 20352431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
    Idbaih A; Boisselier B; Marie Y; El Hallani S; Sanson M; Crinière E; Rodero M; Carpentier C; Paris S; Laigle-Donadey F; Ducray F; Hoang-Xuan K; Delattre JY
    Cancer Genet Cytogenet; 2007 Sep; 177(2):103-7. PubMed ID: 17854663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.
    Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sørensen KM; Porwit A; Humphreys K; Melbye M; Ekström Smedby K
    Cancer Causes Control; 2010 May; 21(5):759-69. PubMed ID: 20087644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.
    Kim HN; Lee IK; Kim YK; Tran HT; Yang DH; Lee JJ; Shin MH; Park KS; Shin MG; Choi JS; Kim HJ
    Br J Haematol; 2008 Feb; 140(3):287-94. PubMed ID: 18042267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
    Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
    Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
    Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults.
    Gemmati D; Ongaro A; Scapoli GL; Della Porta M; Tognazzo S; Serino ML; Di Bona E; Rodeghiero F; Gilli G; Reverberi R; Caruso A; Pasello M; Pellati A; De Mattei M
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):787-94. PubMed ID: 15159311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do childhood diseases affect NHL and HL risk? A case-control study from northern and southern Italy.
    Montella M; Maso LD; Crispo A; Talamini R; Bidoli E; Grimaldi M; Giudice A; Pinto A; Franceschi S
    Leuk Res; 2006 Aug; 30(8):917-22. PubMed ID: 16406019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study.
    Paltiel O; Schmit T; Adler B; Rachmilevitz EA; Polliack A; Cohen A; Haim N; Shachar MB; Epelbaum R; Barchana M; Cohen R; Ben Yehuda D
    Cancer; 2000 May; 88(10):2357-66. PubMed ID: 10820359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.
    Lee JJ; Kim DH; Lee NY; Sohn SK; Kim JG; Kim HJ; Do YR; Park YH
    Br J Haematol; 2007 May; 137(4):329-36. PubMed ID: 17408400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separate diagnoses of Hodgkin lymphoma and non-Hodgkin lymphoma in an individual patient might not signify a common clonal origin.
    Ganzel C; Pogrebijsky G; Krichevsky S; Neuman T; Yehuda DB
    Exp Hematol; 2012 Sep; 40(9):698-704.e2. PubMed ID: 22659385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
    Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
    Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.